{"id":"W2151507583","doi":"10.1634/theoncologist.12-4-426","title":"Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors","year":2007,"lang":"en","type":"review","venue":"The Oncologist","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":418,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Sorafenib; Medicine; Clinical trial; Pharmacokinetics; Refractory (planetary science); Pharmacology; Oncology; Drug; Toxicity; Safety profile; Phases of clinical research; Internal medicine; Medical physics; Adverse effect; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003329077,0.0006980737,0.002896372,0.00193218,0.0002541079,0.001062597,0.001155016,0.0006359826,0.001087339],"category_scores_gemma":[0.004581099,0.0003545491,0.002193464,0.003031531,0.0004921373,0.001081118,0.0004078987,0.0008342118,0.0002975261],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007506566,"about_ca_system_score_gemma":0.001566726,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006792542,"about_ca_topic_score_gemma":0.001782806,"domain_scores_codex":[0.9989202,0.0003125216,0.000369933,0.0001342207,0.0002302259,0.00003291683],"domain_scores_gemma":[0.9960336,0.002241916,0.001026505,0.00007221165,0.0005094334,0.0001164512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001252498,0.00009750547,0.001475196,0.1760388,0.002715233,0.0002687157,0.000233415,0.0005342602,0.004372681,0.0004966516,0.01043837,0.8020767],"study_design_scores_gemma":[0.002272693,0.007158772,0.0318829,0.1676176,0.04431845,0.006744361,0.0008203238,0.0009174586,0.006878522,0.002064865,0.7291472,0.0001768009],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001037387,0.9981744,0.0001741034,0.0001989796,0.0000398906,0.00002919867,0.00006912502,0.000009042171,0.000267875],"genre_scores_gemma":[0.00758832,0.9911885,0.0004534441,0.0003870451,0.00005733298,0.00005065822,0.000127815,0.000007009563,0.000139856],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003329077,"threshold_uncertainty_score":0.01760608,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07306418962376841,"score_gpt":0.4061245175451803,"score_spread":0.3330603279214119,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}